Welcome to LookChem.com Sign In|Join Free

CAS

  • or

167887-37-8

Post Buying Request

167887-37-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

167887-37-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 167887-37-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,8,8 and 7 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 167887-37:
(8*1)+(7*6)+(6*7)+(5*8)+(4*8)+(3*7)+(2*3)+(1*7)=198
198 % 10 = 8
So 167887-37-8 is a valid CAS Registry Number.

167887-37-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-amino-3-(3-methoxy-4-phenylmethoxyphenyl)propanoic acid

1.2 Other means of identification

Product number -
Other names 3-amino-3-(4'-benzyloxy-3'-methoxyphenyl)propionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:167887-37-8 SDS

167887-37-8Relevant articles and documents

Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment

Jourdan, Jean-Pierre,Since, Marc,El Kihel, La?la,Lecoutey, Cédric,Corvaisier, Sophie,Legay, Rémi,Sopkova-De Oliveira Santos, Jana,Cresteil, Thierry,Malzert-Fréon, Aurélie,Rochais, Christophe,Dallemagne, Patrick

, p. 365 - 379 (2016)

This work describes the synthesis and the biological evaluation of novel benzylidenephenylpyrrolizinones as potential antioxidant, metal chelating or amyloid β (βA) aggregation inhibitors. Some derivatives exhibited interesting results in regard to several of the performed evaluations and appear as valuable Multi-Target Directed Ligands with potential therapeutic interest in Alzheimer's disease. Among them, compound 29 particularly appears as a valuable radical and NO scavenger, a Cu(II) and Fe(II) chelating agent and exhibits moderate βA aggregation inhibition properties. These activities, associated to a good predictive bioavailability and a lack of cytotoxicity, design it as a promising hit for further in vivo investigation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 167887-37-8